Rolf Müller

USPTO Granted Patents = 13 (Patent Applications = 10)

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 13 (Patent Applications = 23)

Average Co-Inventor Count = 5.7

ph-index = 1

Forward Citations = 10(Granted Patents)

Location History:

Saarbrücken, DE (2016)
Bremen, DE (2018)
Blieskastel, DE (2013 - 2022)
Braunschweig, DE (2021 - 2022)

Company Filing History:

5 out of 23

Helmholtz-zentrum Fur Infektionsforschung Gmbh

Universitaet Des Saarlandes

patents

4. 1 out of 6

Ursapharm Arzneimittel Gmbh

patents

5. 1 out of 58

Atlas Elektronik Gmbh

patents

6. 1 out of 1

Helmholtz-zentrum Für

patent

7. 1 out of 1

Infektionsforschung Gmbh

patent

8. 1 out of 17

Universität Des Saarlandes

patents

9. 1 out of 23

Helmholtz-zentrum Fuer Infektionsforschung Gmbh

patents

where one patent can have more than one assignee

Years Active: 2013-2022

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11365201 - Chlorotonil derivatives (2022-06-21),

2. 11357752 - Carolacton and derivatives thereof for use in the treatment of cell proliferation disorders (2022-06-14),

3. 11225503 - Crystobactamides (2022-01-18),

4. 11034648 - Cystobactamide derivatives (2021-06-15),

5. 10793600 - Cystobactamides (2020-10-06),

6. 10550397 - Method for producing recombinant 11-de-O-methyltomaymycin (2020-02-04),

7. 10519099 - Cystobactamides (2019-12-31),

8. 10364447 - Production of omega-3 fatty acids by myxobacteria (2019-07-30),

9. 10089883 - Monitoring system for monitoring a watercraft or several watercrafts as well as a process for verifying a watercraft or several watercrafts (2018-10-02),

10. 9422566 - Gene cluster for biosynthesis of griselimycin and methylgriselimycin (2016-08-23),

11. 8791098 - Bioactive pre-tubulysins and use thereof (2014-07-29),

12. 8409840 - Recombinant preparation of selected bromelain fractions (2013-04-02),

13. 8404462 - Synthetic pathway enzymes for the production of argyrins (2013-03-26),

Title: Rolf Müller: A Pioneer in Pharmaceutical Innovation

Introduction: Rolf Müller, an accomplished inventor based in Blieskastel, Germany, has made significant contributions to the field of pharmaceuticals, particularly in the development of new treatments for bacterial infections and malaria. With a remarkable portfolio of 11 patents, Müller stands as a noteworthy figure in the landscape of modern medical research.

Latest Patents: Among his latest innovations are the patents for Chlorotonil derivatives and Crystobactamides. The Chlorotonil derivatives patent pertains to novel chemical compounds represented by a specific formula, aimed at the treatment or prophylaxis of bacterial infections and malaria. Similarly, the Crystobactamides patent focuses on providing cystobactamides intended for combating bacterial infections, showcasing Müller's commitment to addressing critical health challenges through innovative solutions.

Career Highlights: Throughout his career, Müller has worked with prestigious organizations that support his research endeavors. Notably, he has been associated with the Helmholtz Centre for Infection Research and Sanofi, two institutions known for their commitment to advancing healthcare solutions and pharmaceutical development.

Collaborations: Rolf Müller has collaborated with talented professionals in his field, including colleagues Jennifer Herrmann and Kathrin Mohr. These partnerships have likely contributed to his innovative work and success in securing patents that enhance treatments for infectious diseases.

Conclusion: Rolf Müller exemplifies the spirit of innovation in the pharmaceutical industry. His dedication to research and development has led to valuable patents that address pressing health issues. As new challenges arise in medicine, inventors like Müller continue to play a critical role in finding solutions that can benefit society at large.

This text is generated by artificial intelligence and may not be accurate.